CMS creates new preventive medicine benefits via National Coverage Determinations. On February 28, 2020, CMS it was reviewing the FDA-approved Epi proCOlon test for coverage. CMS: Here. My blog: here. CMS took 30 days of public comment at that time (comments posted on CMS website).
Heads up - the six month timeline for CMS to produce a proposed NCD is nearly passed. The deadline is August 28. Look for a proposed NCD from CMS on or around the 28th.
__
AHRQ Too
In the interval, in May 2020, AHRQ announced it was doing a broad review of the liquid biopsy space for detection and recurrence monitoring; my blog and links on that effort, here.
_____
FDA Too
Also in the past months, FDA held a one-day workshop on circulating tumor DNA for cancer screening, March 9, 2020. Homepage here, 157 page transcript here.
____
CMS NCD Agenda: |
| click to enlarge |